John T Randolph Selected Research

John T Randolph Research Topics

3	Infections 10/2018 - 06/2004
2	Hyperbilirubinemia 04/2009 - 02/2006
1	Neoplasms (Cancer) 01/2023
1	Necrosis 12/2022
1	Contact Dermatitis (Eczema, Contact) 12/2022
1	Lactic Acidosis 04/2010
1	Hyperlipidemias (Hyperlipidemia) 04/2010
1	Insulin Resistance 04/2010
1	HIV Infections (HIV Infection) 01/2004

3	Protease Inhibitors (Protease Inhibitor)IBA 04/2010 - 01/2004
2	NucleosidesIBA 01/2018 - 04/2010
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	alanylalanine (Ala-Ala)IBA 12/2022
1	Viekira PakIBA 10/2018
1	ombitasvirIBA 10/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	ABT-072IBA 01/2018
1	HIV Protease InhibitorsIBA 04/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2010
1	BilirubinIBA 04/2009
1	amprenavir (Agenerase)FDA Link 02/2006
1	Ritonavir (Norvir)FDA Link 02/2006
1	Indinavir (Crixivan)FDA Link 02/2006
1	Atazanavir Sulfate (Reyataz)FDA Link 02/2006
1	BILN 2061IBA 06/2004
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2004
1	PeptidomimeticsIBA 01/2004

1	Therapeutics 01/2023
1	Duration of Therapy 10/2018
1	Highly Active Antiretroviral Therapy (HAART) 04/2010